Skip to Main text
Nitto always aims for fair disclosure to ensure that our investors can properly evaluate our corporate value.
|2016/Oct/12||Nitto Denko Avecia Inc. Acquires Assets of Irvine Pharmaceutical Services & Avrio Biopharmaceuticals|
|2016/Sep/27||2016/Oct/31 Announcement of Financial Results for 2Q, FY2016|
|2016/Sep/20||Establishment of the Basic Procurement Policy and CSR-Based Procurement Guidelines|
Back to Page Top